Cargando…
Safety and Efficacy of Long‐Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open‐Label Extension Study
BACKGROUND: Tourette syndrome (TS) is a neurodevelopmental disorder characterized by motor and phonic tics. OBJECTIVE: To assess the safety and efficacy of deutetrabenazine (Teva Neuroscience, Inc, Parsippany, NJ), a vesicular monoamine transporter 2 inhibitor, in children and adolescents with TS. M...
Autores principales: | Jankovic, Joseph, Coffey, Barbara, Claassen, Daniel O., Jimenez‐Shahed, Joohi, Gertz, Barry J., Garofalo, Elizabeth A., Stamler, David A., Wieman, Maria, Savola, Juha‐Matti, Harary, Eran, Alexander, Jessica, Barkay, Hadas, Gordon, Mark Forrest |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525047/ https://www.ncbi.nlm.nih.gov/pubmed/37772282 http://dx.doi.org/10.1002/mdc3.13849 |
Ejemplares similares
-
Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial
por: Coffey, Barbara, et al.
Publicado: (2021) -
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial
por: Jankovic, Joseph, et al.
Publicado: (2021) -
Deutetrabenazine in Tics Associated with Tourette Syndrome
por: Jankovic, Joseph, et al.
Publicado: (2016) -
Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study
por: Hauser, Robert A., et al.
Publicado: (2022) -
Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect
por: Schneider, Frank, et al.
Publicado: (2020)